aicéatáit abiraterone, Janssen Biotech, MÉIDEACHT, mCRPC, Niraparib
Tá aicéatáit Niraparib agus abiraterone móide prednisone ceadaithe ag FDA le haghaidh ailse próstatach meiteastatach atá frithsheasmhach in aghaidh coilleadh BRCA
Lúnasa 2023: Tá an meascán dáileog seasta de niraparib agus aicéatáit abiraterone (Akeega, Janssen Biotech, Inc.), in éineacht le prednisone, ceadaithe ag an Riarachán Bia agus Drugaí d'othair aosach a bhfuil resistant coilleadh orthu.
Bayer HealthCare Pharmaceuticals Inc, Darolutamide, doctaxel, Nubeq
Tá táibléad Darolutamide ceadaithe ag FDA le haghaidh ailse próstatach meiteastatach atá íogair ó thaobh hormóin
August 2022: Darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) tablets combined with docetaxel were approved by the Food and Drug Administration for adult patients with metastatic hormone-sensitive prostate cancer (mHS..
gallium Ga 68 gozetotide, Locametz, lutetium Lu 177 vipivotide tetraxetan, mCRPC, Novartis, Pluvicto, PSMA
Tá Pluvicto ceadaithe ag FDA le haghaidh ailse próstatach meiteastatach atá resistant do choilleadh
April 2022: The Food and Drug Administration approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan, Advanced Accelerator Applications USA, Inc., a Novartis company) for the treatment of adult patients with prostate-specific mem..
Doppler, ED, dysfunction erectile, HIFU, HIFU beam, Ultrafhuaim Dírithe Ard-Déine, prostate cells
Ultrafhuaim Dírithe Ard-Déine
March 2022: HIFU (High Intensity Focused Ultrasound) is a cutting-edge therapy that uses focused, high-energy ultrasound waves to heat and kill cancerous parts of the prostate gland. The target tissue is heated to 880 to 980 degre..
GnRH, Laoch, Eolaíochtaí Myovant, oral gonadotropin-releasing hormone, ORGOVYX, freasadóir gabhdóra, relugolix
Tá relugolix ceadaithe ag an FDA chun cóireáil a dhéanamh ar ard-ailse próstatach
August 2021: The first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix (ORGOVYX, Myovant Sciences, Inc.), was approved by the Food and Drug Administration on December 18, 2020, for adult patients with met..